Search Results - "Duong, Sophie L."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Decreased Polycystin 2 Levels Result in Non-Renal Cardiac Dysfunction with Aging by Kuo, Ivana Y, Duong, Sophie L, Nguyen, Lily, Ehrlich, Barbara E

    Published in PloS one (15-04-2016)
    “…Mutations in the gene for polycystin 2 (Pkd2) lead to polycystic kidney disease, however the main cause of mortality in humans is cardiac related. We…”
    Get full text
    Journal Article
  2. 2

    Molecular disease mechanisms of human antineuronal monoclonal autoantibodies by Duong, Sophie L., Prüss, Harald

    Published in Trends in molecular medicine (01-01-2023)
    “…Autoantibodies targeting brain antigens can mediate a wide range of neurological symptoms ranging from epileptic seizures to psychosis to dementia. Although…”
    Get full text
    Journal Article
  3. 3

    Paraneoplastic Autoimmune Neurological Syndromes and the Role of Immune Checkpoint Inhibitors by Duong, Sophie L., Prüss, Harald

    Published in Neurotherapeutics (01-04-2022)
    “…The introduction of immune checkpoint inhibitors (ICIs) in oncologic therapies has led to a paradigm shift in cancer treatment. ICIs have increased the overall…”
    Get full text
    Journal Article
  4. 4

    Neurotoxicities associated with immune checkpoint inhibitor therapy by Duong, Sophie L., Barbiero, Frank J., Nowak, Richard J., Baehring, Joachim M.

    Published in Journal of neuro-oncology (01-04-2021)
    “…Introduction Immune checkpoint inhibitors (ICIs) have emerged as a promising class of cancer immunotherapies. Neurotoxicities are uncommon, but often severe,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Spätfolgen nach Immuntherapie: Immunvermittelte Nebenwirkungen von Checkpointinhibitoren by Duong, Sophie L., Zierold, Sarah, Kramer, Rafaela, Reincke, Martin, Kerl-French, Katrin, Boehmerle, Wolfgang, Pavel, Marianne, Weckbach, Ludwig, French, Lars E., Knauss, Samuel, Heinzerling, Lucie

    Published in Der Onkologe (01-08-2021)
    “…Zusammenfassung Hintergrund Immuncheckpointinhibitoren (ICI) sind bei zahlreichen Tumorentitäten wirksam, können allerdings immunvermittelte Nebenwirkungen in…”
    Get full text
    Journal Article